Our findings reveal a significant overrepresentation of PI3K and TP53 pathway alterations in early‐onset Hispanic/Latino CRC patients compared to their non‐Hispanic White counterparts, suggesting potential molecular mechanisms underlying CRC disparities in this population. The gene discussed is TP53; the disease is colorectal carcinoma.